ARS Pharmaceuticals Ownership & Insider Activity

ARS Pharmaceuticals (SPRY) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 8.1% of shares outstanding. Institutional investors hold 24.3%.

Shares Outstanding

99.447M

Shares Float

68.973M

Insider Shares Owned

8.095M

Insider % Owned

8.1%

Institutional Shares Held

24.145M

Institutional % Held

24.3%

Ownership Breakdown

Net Insider Activity by Month

ARS Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Jun 12, 2026	Eric Karas	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$5.75	$213K
Jun 12, 2026	Alexander Fitzpatrick	CHIEF LEGAL OFFICER	SELL	3.355K	$10.00	$34K